LEGN Performance: -41.8% Return (12 Months)

LEGN returned -41.8% over 12 months, underperforming the S&P 500 (23.6%). Volatility: 49.1%.

RS IBD -47.17
Top 96% in Peers
Volatility 49.1%
Top 22% in Peers
Total Return 12m -41.79%
Top 95% in Peers
RS Rating 8.03
Top 96% in Peers
P/E
P/E Trailing 0.00
P/E Forward 86.2
High / Low 52w
52 Week High 44.32 USD
52 Week Low 16.65 USD
Sentiment
VRO Trend Strength ±100 69.31
Buy Signal ±3 -0.60
Drawdowns 3y
Max Drawdown 78.24%
Mean Drawdown 38.95%
Compare performance with 200 peers in Biotechnology
12m Total Return: LEGN (-41.8%) vs SPY (23.6%) Total Return of Legend Biotech versus its related sector ETF SPY
5y Drawdown (Underwater) Chart 5 Year Drawdown / Underwater Chart for LEGN Performance: -41.8% Return (12 Months)

Top Performer in Biotechnology (5/200)

Short Term Performance
SYMBOL 1W 1M 3M
ERAS 18.97% 26.31% 410.32%
DAWN 0.19% 113.86% 150.88%
TNGX 12.31% 88.09% 142.76%
DNTH 6.00% 55.26% 133.13%
ORKA 19.85% 62.33% 98.33%
LEGN 13.93% 7.17% -5.76%
Long Term Performance
SYMBOL 6M 12M 5Y
ABVX 41.05% 1944.39% 920.43%
ABVX 40.44% 1781.26% 412.12%
TNGX 178.74% 1603.15% 96.82%
ERAS 635.95% 1371.90% 2.18%
PRAX 470.76% 832.07% -37.39%
LEGN -40.30% -41.79% -34.14%
Overall Best Picks of Peer Group (GARP Metrics)
SYMBOL MCAP 1M 12M 5Y P/E P/E fwd PEG EPS stab EPS cagr
ROIV NASDAQ
Roivant Sciences		 19.9B 1.72% 183% 189% - - - 37.2% -14.4%
UTHR NASDAQ
United Therapeutics		 25.8B 13.3% 83.8% 193% 18.8 19.3 2.17 -2.20% -35.9%
DAWN NASDAQ
Day One Biopharmaceuticals		 2.21B 114% 178% -17.2% - - - 57.3% 49.0%
GLUE NASDAQ
Monte Rosa Therapeutics		 1.24B -4.84% 339% -19.3% - 10.0 - 59.8% 43.8%
KRYS NASDAQ
Krystal Biotech		 7.57B -1.08% 46.5% 231% 37.9 44.8 - 84.4% 26.5%
STRO NASDAQ
Sutro Biopharma		 79.1M 20.7% 301% -90.0% - 8.96 - -29.4% -68.0%
PHARM AS
Pharming		 1.18B 6.38% 100% 30.2% - 100 - -4.20% -
AUPH NASDAQ
Aurinia Pharmaceuticals		 1.90B 10.3% 93.9% 20.1% 6.89 20.5 - 63.8% 123%
TVTX NASDAQ
Travere Therapeutics		 2.51B 7.68% 83.8% 15.3% - 41.0 - 82.4% 24.9%
IRWD NASDAQ
Ironwood Pharmaceuticals		 572M -2.75% 160% -67.8% 23.4 12.3 -0.26 -58.4% -20.7%

Performance: LEGN vs S&P 500

Total Return vs S&P 500
PERIOD LEGN S&P 500 DIFFERENCE
1 Month 7.17% -3.34% 10.87%
3 Months -5.76% -4.38% -1.45%
6 Months -40.30% -1.44% -39.43%
12 Months -41.79% 23.60% -52.90%
5 Years -34.14% 72.80% -61.89%

LEGN Performance FAQ

Does LEGN outperform the market?

No, LEGN underperforms the market. Over the past 12 months, LEGN returned -41.79% compared to 23.60% for the S&P 500.

What is the LEGN return over the last 12 months?

LEGN has returned -41.79% over the past 12 months, including dividends. Over 3 months the return was -5.76%, and over 5 years -34.14%.

How risky is LEGN?

LEGN has relatively low risk with a maximum drawdown of 78.24% over the past 3 years. The average drawdown is 38.95%.

LEGN vs Sectors (12m)

Sorted by outperformance. Positive = LEGN beats sector.

Relative Performance vs S&P Sectors
SECTOR ETF DIFFERENCE 12M
Consumer Staples XLP -44.4%
Health Care XLV -46.2%
Financials XLF -47.3%
Real Estate XLRE -47.3%
Consumer Discretionary XLY -55.9%
Consumer Discretionary XLY -55.9%
Communication Services XLC -64%
Materials XLB -65.5%
Industrials XLI -73.7%
Technology XLK -81.9%
Energy XLE -82.8%

LEGN vs Asset Classes (12m)

Relative Performance vs Major Asset Classes
ASSET CLASS ETF DIFFERENCE 12M
S&P 500 SPY -52.90%
Gold GLD -91.7%
Long-Term Bonds TLT -40.6%